Orally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety.
Leander, Peter
Orally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety. [electronic resource] - Investigative radiology Sep 2010 - 559-64 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1536-0210
10.1097/RLI.0b013e3181e960ab doi
Abdomen--diagnostic imaging
Administration, Oral
Adult
Antioxidants--administration & dosage
Ascorbic Acid--administration & dosage
Biomarkers
Contrast Media--administration & dosage
Cross-Over Studies
Drug Therapy, Combination
Humans
Intestine, Large--diagnostic imaging
Liver--diagnostic imaging
Male
Manganese--administration & dosage
Radionuclide Imaging
Statistics as Topic
Time Factors
Trace Elements--administration & dosage
Orally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety. [electronic resource] - Investigative radiology Sep 2010 - 559-64 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1536-0210
10.1097/RLI.0b013e3181e960ab doi
Abdomen--diagnostic imaging
Administration, Oral
Adult
Antioxidants--administration & dosage
Ascorbic Acid--administration & dosage
Biomarkers
Contrast Media--administration & dosage
Cross-Over Studies
Drug Therapy, Combination
Humans
Intestine, Large--diagnostic imaging
Liver--diagnostic imaging
Male
Manganese--administration & dosage
Radionuclide Imaging
Statistics as Topic
Time Factors
Trace Elements--administration & dosage